Tender detail
Multi-supplier framework agreement for ondansetron, netupitant/palonosetron and aprepitant for Vivalia pharmacies
Summary
Vivalia is procuring medicines for its pharmacies through a four-year, multi-supplier framework agreement with five lots: ondansetron 8 mg oral, ondansetron 8 mg/4 ml IV, ondansetron 4 mg/2 ml IV, netupitant/palonosetron 300 mg/0.5 mg oral, and aprepitant 125 mg plus two 80 mg oral doses. The ordered quantities are not fixed in advance, and supplies are intended for Vivalia’s sites.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.